These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 14574875)

  • 1. [Diagnosis of colorectal cancer with FDG-PET].
    Uno K
    Nihon Rinsho; 2003 Sep; 61 Suppl 7():168-72. PubMed ID: 14574875
    [No Abstract]   [Full Text] [Related]  

  • 2. Positron emission tomography (PET) in the evaluation of patients with cancer.
    Godwin HA; Zuger JH
    Trans Am Clin Climatol Assoc; 1999; 110():181-94. PubMed ID: 10344016
    [No Abstract]   [Full Text] [Related]  

  • 3. Selection of patients for resection of hepatic metastases: improved detection of extrahepatic disease with FDG pet.
    Zealley IA; Skehan SJ; Rawlinson J; Coates G; Nahmias C; Somers S
    Radiographics; 2001 Oct; 21 Spec No():S55-69. PubMed ID: 11598248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Positron emission tomography in colorectal cancer.
    Flamen P
    Best Pract Res Clin Gastroenterol; 2002 Apr; 16(2):237-51. PubMed ID: 11969236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Positron emission tomography and colorectal carcinoma: an update.
    Tzimas GN; Koumanis DJ; Meterissian S
    J Am Coll Surg; 2004 Apr; 198(4):645-52. PubMed ID: 15051018
    [No Abstract]   [Full Text] [Related]  

  • 6. A new imaging technique for colorectal cancer: positron emission tomography.
    Flamen P; Van Cutsem E; Mortelmans L
    Semin Oncol; 2000 Oct; 27(5 Suppl 10):22-9. PubMed ID: 11049029
    [No Abstract]   [Full Text] [Related]  

  • 7. Oncological applications of FDG PET imaging.
    Delbeke D
    J Nucl Med; 1999 Oct; 40(10):1706-15. PubMed ID: 10520713
    [No Abstract]   [Full Text] [Related]  

  • 8. Positron emission tomography for evaluation of colorectal carcinoma.
    Vitola J; Delbeke D
    Semin Roentgenol; 2002 Apr; 37(2):118-28. PubMed ID: 12134365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oncological applications of FDG PET imaging: brain tumors, colorectal cancer, lymphoma and melanoma.
    Delbeke D
    J Nucl Med; 1999 Apr; 40(4):591-603. PubMed ID: 10210218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Positron emission tomography (PET) in clinical oncology. Part II].
    Cabrera Villegas A; Gámez Cenzano C; Martín Urreta JC
    Rev Esp Med Nucl; 2002 Apr; 21(2):131-47; quiz 149-51. PubMed ID: 11879626
    [No Abstract]   [Full Text] [Related]  

  • 11. Performance evaluation of principal component analysis in dynamic FDG-PET studies of recurrent colorectal cancer.
    Thireou T; Strauss LG; Dimitrakopoulou-Strauss A; Kontaxakis G; Pavlopoulos S; Santos A
    Comput Med Imaging Graph; 2003; 27(1):43-51. PubMed ID: 12573889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The clinical impact of camera-based positron emission tomography imaging in patients with recurrent colorectal cancer.
    Miller E; Lerman H; Gutman M; Figer A; Livshitz G; Even-Sapir E
    Invest Radiol; 2004 Jan; 39(1):8-12. PubMed ID: 14701983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of positron emission tomography in the management of colorectal cancer.
    Tutt AN; Plunkett TA; Barrington SF; Leslie MD
    Colorectal Dis; 2004 Jan; 6(1):2-9. PubMed ID: 14692944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Value of positron emission tomography in the diagnosis of recurrent oesophageal carcinoma.
    Kato H; Miyazaki T; Nakajima M; Fukuchi M; Manda R; Kuwano H
    Br J Surg; 2004 Aug; 91(8):1004-9. PubMed ID: 15286962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Positron emission tomography and colorectal cancer.
    Arulampalam TH; Costa DC; Loizidou M; Visvikis D; Ell PJ; Taylor I
    Br J Surg; 2001 Feb; 88(2):176-89. PubMed ID: 11167864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Positron emission tomography imaging of colorectal cancer.
    Akhurst T; Larson SM
    Semin Oncol; 1999 Oct; 26(5):577-83. PubMed ID: 10528907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of FDG-PET on the management algorithm for recurrent colorectal cancer.
    Arulampalam T; Costa D; Visvikis D; Boulos P; Taylor I; Ell P
    Eur J Nucl Med; 2001 Dec; 28(12):1758-65. PubMed ID: 11734912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The clinical application of positron emission tomography to colorectal cancer management.
    Arulampalam TH; Costa DC; Bomanji JB; Ell PJ
    Q J Nucl Med; 2001 Sep; 45(3):215-30. PubMed ID: 11788814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differentiating recurrent or residual nasopharyngeal carcinomas from post-radiotherapy changes with 18-fluoro-2-deoxyglucose positron emission tomography and thallium-201 single photon emission computed tomography in patients with indeterminate computed tomography findings.
    Tsai MH; Huang WS; Tsai JJ; Chen YK; Changlai SP; Kao CH
    Anticancer Res; 2003; 23(4):3513-6. PubMed ID: 12926100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Where can FDG-PET contribute most to anatomical imaging problems?
    Bingham JB
    Br J Radiol; 2002 Nov; 75 Spec No():S39-52. PubMed ID: 12519735
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.